ResearcherChampalimaud FoundationActive in the last 2 years

Dário Ligeiro

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5306-3679; OpenAlex author ID A5021030728. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

Tumor-Infiltrating Natural Killer Cell Characterization in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cells15090797 ↗
B Cells in the Gastrointestinal Tumor Microenvironment with a Focus on Pancreatic Cancer: Opportunities for Precision Medicine? Co-author DOI 10.1007/978-3-030-49270-0_10 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Mireia Castillo-Martín · 2 shared papers, 2020–2026 · strength 0.41
- Paper Tumor-Infiltrating Natural Killer Cell Characterization in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cells15090797 ↗
- Paper B Cells in the Gastrointestinal Tumor Microenvironment with a Focus on Pancreatic Cancer: Opportunities for Precision M… DOI 10.1007/978-3-030-49270-0_10 ↗
Andreia Maia · 2 shared papers, 2020–2026 · strength 0.41
- Paper Tumor-Infiltrating Natural Killer Cell Characterization in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cells15090797 ↗
- Paper B Cells in the Gastrointestinal Tumor Microenvironment with a Focus on Pancreatic Cancer: Opportunities for Precision M… DOI 10.1007/978-3-030-49270-0_10 ↗
Markus J. Maeurer · 2 shared papers, 2020–2026 · strength 0.41
- Paper Tumor-Infiltrating Natural Killer Cell Characterization in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cells15090797 ↗
- Paper B Cells in the Gastrointestinal Tumor Microenvironment with a Focus on Pancreatic Cancer: Opportunities for Precision M… DOI 10.1007/978-3-030-49270-0_10 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.